HABERSHAM MEDICAL CENTER — History
CCN 110041 | 3-year financial timeline | COVID resilience: 36/100
🛡️ Public data only — no PHI permitted on this instance.
$49M
Latest Revenue (FY2022)
+1.3%
Revenue CAGR (3yr)
-27.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $47M | $52M | $49M | -6.7% | +1.3% |
| Operating Expenses | $56M | $68M | $62M | -9.3% | +5.2% |
| Operating Margin | -18.1% | -30.9% | -27.3% | +11.6% | +0.0% |
| Net Income | $-9M | $-16M | $-13M | +17.6% | +0.0% |
| Licensed Beds | 53 | 53 | 53 | +0.0% | +0.0% |
| Total Patient Days | 6,616 | 7,178 | 3,729 | -48.0% | -24.9% |
| Medicare Day % | 30% | 27% | 27% | +1.6% | -4.7% |
| Medicaid Day % | 6% | 7% | 9% | +26.0% | +20.0% |
COVID Impact & Recovery
Resilience Score: 36/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +2.7% ($47M → $49M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.3%
This Hospital
+7.6%
State Avg
Latest Margin
-27.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $49M | -31.9% |
| FY2024 (proj) | $50M | -36.5% |
| FY2025 (proj) | $50M | -41.2% |